Avanos Medical has patented a system for treating pain by selectively modulating neural and non-neural tissue in the nervous system. The device delivers electrical stimulation to inhibit pain perception while preserving sensory and motor function. The method is safe and reversible, ensuring no damage to tissues. GlobalData’s report on Avanos Medical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Avanos Medical, was a key innovation area identified from patents. Avanos Medical's grant share as of April 2024 was 61%. Grant share is based on the ratio of number of grants to total number of patents.
Transmucosal electrical stimulation system for pain treatment
A recently granted patent (Publication Number: US11951311B2) discloses a system designed to modulate targeted neural and non-neural tissue of a nervous system structure to treat various medical conditions in patients. The system includes an electrical stimulation device with an electrode that delivers transmucosal electrical stimulation to a treatment site proximate the targeted tissue. A controller connects to the electrode and a power source, directing the device to selectively modulate the tissue to inhibit pain perception while preserving sensory and motor functions. The system's parameters, such as waveform shape, frequency, and amplitude, can be adjusted to ensure the safety and effectiveness of the treatment.
The system is particularly useful in treating conditions like head-and-face pain, migraines, and neuralgias by delivering transmucosal electrical stimulation through electrodes placed on mucosal tissues like oral, nasal, gastrointestinal, bowel, or bladder mucosa. By targeting specific nerve fibers responsible for pain transmission while preserving other sensory and motor functions, the system offers a non-invasive and reversible method of pain management. The controller can vary the stimulation parameters based on feedback from temperature sensors, patient input, or physiological responses, ensuring optimal treatment outcomes. Additionally, a cooling mechanism can be employed to prevent tissue damage during the procedure, making the system a safe and effective option for patients suffering from various medical conditions related to neural and non-neural tissue dysfunction.
To know more about GlobalData’s detailed insights on Avanos Medical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
